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ABSTRACT 
DEVELOPMENT OF A NITRIC OXIDE MEASUREMENT METHOD IN TISSUE 
MEDIA
Nitric oxide (NO) is involved in many biological pathways such as vasodilatation 
and cellular migration. The biological roles of NO have been most heavily investigated 
using cell and tissue culture models.  The limitations with current analytical measurement 
methods used most commonly with these studies, however, are that they often do not 
record in real-time or measure NO directly. This makes it difficult to understand the 
concentration dependent response activity of NO. To overcome these limitations, a 
measurement method has been developed that enables the real-time measurement of NO 
in buffered tissue media (pH 7.4, buffered with CO2 gas, 37 °C). The design of our 
system included multi-volume custom sample cells with a pH probe and multiple gas 
supply inputs, a flow regulated CO2 gas system and a chemiluminescence detector.  
Results demonstrated the expected first–order NO release kinetics using a model NO 
donor (MAHMA/NO) in phosphate buffered saline (PBS) over a specified volume range.  
The following half-lives were found:  63 2 s (2 mL), 65 2 s (6 mL), 63 4 s (8 mL) and 
67 9 s (10 mL).  Using this method at these buffer volumes, an experiment was 
conducted using 11 mM MAHMA/NO stock used to demonstrate that NO release was 
linearly proportional with respect to buffer volume with a linear fit of R2=0.9936. The 
linearity of NO release allowed NO release measurements of 4.4 x10-7 M MAHMA/NO 
concentration in 10 mL PBS achieving NO recovery of 117 2 and MAHMA/NO 
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decomposition half-lives 66 2. The analysis of a 10-7 M MAHMA/NO was not 
measurable previously using other chemiluminescence methods.  
Subsequent results in tissue media buffered with 5% CO2 at a controlled rate of 20 
mL/min showed statistically similar kinetic rates 68 5 s (2 mL) to that of the PBS, 
demonstrating the ability to measure NO in real time under tissue conditions.  The 
simultaneous pH measurements confirmed that the pH was constant at 7.4 during the NO 
release portion of the experiment, an important aspect to maintain accurate kinetics. 
Using this method for NO release measurement in tissue media, another NO donor, 
DETA/NO, was used to look at steady-state release for 1.5 h. The total NO release was 
0.12 0.02 (nmol) and the NO release rate was 22 3 (fmol/s). This is the first analytical 
measurement method that enables detection of NO release from NO donors in buffered 
tissue media method mimicking in vitro condition.
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In the late 1700’s Sir Humprey Davy conducted the very first experiment to study the 
effect of nitric oxide (NO) on respiration. The experiment was ill conceived, where he 
experienced aspiration pneumonitis and nearly died from inhalation of the gas and stated, 
‘never design again to attempt so rash an experiment’.1 In the 1900’s until the early 
1980’s, NO was generally studied as an important gas in the atmosphere because of its 
role in acid rain, smog and depletion of the ozone layer.2,3 In 1987, the endothelium-
derived relaxing factor (EDRF) was discovered to be NO responsible for 
vasodilatation.4,5 This established NO as an important molecule in physiological biology.6 
This discovery, also caused an increased research interest in the chemical and biological 
effects of NO throughout the 1990’s. Since then NO has been shown to be an important 
signaling molecule in vascular, neuronal and immune response pathways summarized in 
Figure 1.1.7  
 
 
Figure 1.1: Nitric oxide is an important signaling molecule involved in many 
biological processes and cellular responses in vivo.  
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The significance of NO in biology was recognized by the 1998 Nobel Prize in Physiology 
and Medicine given to Furchgott, Ignarro and Murad for their work in establishing NO as 
a chemical signaling agent in physiology.8,9  
 In this introduction, the role of NO in many important biological processes will be 
discussed.  In addition, the use of NO donor compounds to better elucidate the role of NO 
in cellular processes and the specific analytical techniques used to detect NO release from 
these compounds will be described. Finally, the rationale for the development of 
analytical methodologies that allow for the detection of NO in conditions that mirror 
those of tissue studies will provide the context for this work.   
1.1 Biological Impact of NO 
 
 Nitric oxide, as an important biological molecule begins with the discovery that 
NO plays an unique role in the cardiovascular system. Today’s understanding of 
vasodilatation had its roots in the 1970’s, where researchers investigated why 
nitroglycerin was such a powerful heart attack medicine and the mechanism for its 
biological activity.10 Murad and colleagues explored these questions by studying how 
nitroglycerin, nitropusside and NO influenced guanlylate cyclase (GC) activity.11 Using 
these sources of NO, NO was found to stimulate a measurable increase in GC in several 
tissue models. Murad implicated this increase in GC to the presence of NO, a hormone 
or another endogenous compound; however, this study did not produce concrete 
experimental evidence to elucidate NO’s role in this hypothesis.12 The experimental 
evidence strongly suggest that NO was responsible for the increase in GC activity first 
reported by Ignarro, whose published work demonstrated that oxyhemglobin inhibited 
endothelium and NO-induced relaxation in bovine intrapulmonary arteries and veins.4 
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This work provided evidence that cyclic guanosine monophosphate (cGMP) levels were 
elevated by EDRF and demonstrated that the EDRF was NO.  Two months later, Palmer 
independently determined that the EDRF was NO by performing an inhibition study 
using haemoglobin and a tissue bioassay.5 Palmer and colleagues were able to state that 
“the biological activity of the EDRF is accounted for by NO” and served to expand the 
work presented by Ignarro.5  
Cardiovascular System: 
Twenty-five years have passed since NO was first implicated as the EDRF and 
demonstrated to be responsible for the vasodilatation of blood vessels. In this time, NO’s 
involvement in the cardiovascular system has been expanded. For example, several 
studies have been published that demonstrate NO’s role in preventing platelet 
adhesion.10,13 Furlong showed that anti-platelet adhesion could be inhibited by 
haemoglobin scavenging of NO, at a binding affinity rate of 1015 M-1.14,15 Additional 
work showed that NO was largely responsible for blood pressure regulation.10 
Researchers investigated the role of NO in blood pressure by inhibiting NO synthesis 
using N -monomethyl-L-argine (L-NMMA) in both in vivo and in vitro models of 
hypertension.16 This work was further confirmed by a study investigating multi-vascular 
beds in a rat model, where NO was inhibited through L-NMMA again resulting in the 
development of hypertension.17 
Bronchodilation:
Nitric oxide’s role is not limited to the cardiovascular system but has also been 
demonstrated to play an important role in respiration of organisms. Inhalation 
experiments in guinea pigs demonstrated that NO could serve as a powerful 
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bronchodilator. In these studies, the animals were exposed to low concentrations of NO 
gas, and the bronchoconstriction of the animals was reversed.18 Similar experiments 
were done independently that served to explain how the bronchodilator response was 
mediated in the lungs using human tracheal segments harvested from five individuals, 
who met qualification for heart-lung transplants.19 This study used the tracheal rings to 
suggest that nerve cells controlled NO release that induced bronchodilation.19 Data from 
these studies showed the controlled inhibition or activation of dilation in bronchi in 
human lungs. Other work found that NO was present in exhaled air of humans and was 
shown to be elevated in asthmatic patients.20,21 This work combined with many others 
have examined the role of NO and respiration leading to important new developments in 
asthma treatment and dosaging.22  
Immune Response: 
By the late 1980’s and the early 1990’s, NO was also implicated in controlling 
immune response.  Nitric oxide was found to be expressed by macrophages and function 
as a tumoricidal and antimicrobial agent.7 Investigators, first found that macrophages 
produced NO as a response to infection.23,24 Patients suffering from infections ranging 
from hepatitis, tuberculosis, malaria and rheumatoid arthritis expressed NO at higher 
levels than the control patients.25 Through experimental studies, NO donor molecules 
were used to demonstrate the validity that NO has a strong anti-microbial activity in
vivo. NO releasing compounds were shown to successfully inhibit or kill microbes and 
the anti-microbial activity of NO was demonstrated to be effective against viruses, 
bacteria, fungi and parasites.26 Several studies have found that NO synthesis is not 
limited to macrophages, but is produced in many other cell lines including phagocytes, 
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dendritic, natural killer and T and B cells. The production of NO within these cell lines 
supports its role in immune response.  
Central Nervous System: 
In the central nervous system, NO has been implicated to influence the perception 
of pain and the control of sleep, hunger, body temperature and neurosection of 
hormones.27 Based on the work of several studies, NO is hypothesized to play a part in 
how the central nervous system processes pain.28 The relationship between NO and the 
pain receptor, nociceptor; however, is not fully understood at this time.29 Holthusen et al. 
investigated the direct relationship between NO and pain perception by injecting 
volunteers with varying amounts of NO dissolved in phosphate buffer and correlating the 
injection with a pain response.29 These researchers found that when a 12 nmol dose of 
NO was injected directly into volunteers, it always induced a pain responds in the 
volunteer. Zhang et al. demonstrated that NO production occurred within the primary 
sensory neurons in rats, linking NO to localized tenderness called hyperalgesic pain.30,31  
The regulation of the sleep-wake cycle is considered to be influenced by NO 
based on observable changes to the cycle following NO inhibition experiments and 
infusions of NO donor molecules in mouse and cat models.32 As with the vasodilatation 
effect of NO in blood vessels, the release of NO from nerve cells induces smooth muscle 
relaxation throughout the gastrointestinal tract. This relaxation allows the esophagus to 
push food into the stomach, which aids the stomachs to digest large amounts of food 
without producing pressure fluctuations within the stomach.33 As well as stimulating 
digestion, NO has also been shown to influence the appetite in rat, mice and chicken 
models.34 In the brain, many biological processes are regulated by NO through 
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neurosecretion of hormones influencing sleep and stress.27 Neurosecretion of hormones 
occur through stimulation from NO because it act as a neurotransmitter, making it an 
important cellular messenger in the brain. Garthwaite et al. first reported this observation, 
when receptors in cellebellar cells released NO after being stimulated by glutamate.35 
Later, NO’s involvement in promoting the release of neurotransmitters like acetylcholine, 
noradrenaline and gamma amino butyric acid (GABA) was discovered.27  
1.2 Synthesis of NO in vivo 
Nitric oxide has a wide range of influences within mammals, and in the last 
decade, the molecule has continued to be studied for its biological effects. Moving 
forward, the monitoring of NO will become increasingly important as researchers use 
their knowledge of what NO does to treat aliments caused by NO deficiencies.  Before 
these deficiencies can be addressed, it is important to understand how NO is produced in
vivo to induce these behavioral changes in organisms. 
After Ignarro and Palmer demonstrated that NO was the EDRF, other researchers 
showed that NO is responsible for a number of crucial biological processes. However, no 
one understood how this endogenous source of NO was produced in vivo. In 1989, 
Mayer found that endothelial cells produced NO through an enzymes termed nitric oxide 
synthase (NOS).36 Dawson and Synder expanded on this finding by demonstrating that 







This two-step synthesis NO occurs within endothelial cells by the oxidation of L-arginine 
to L-citrulline by nitric oxide synthase (NOS) and these reactions are catalyzed by 
nicotinamide adenine dinucleotide phosphate (NADPH) and oxygen (Figure 1.2). 
 
NO production in vivo is accomplished primarily by NOS, of which there are three main 
isoforms: endothelial (eNOS), neuronal (nNOS), and inducible (iNOS).38 The isolation of 
NOS first came in the brain by work performed by Bredt et al. and was supported by 
experimental evidence finding NOS in several different cell types including endothelium 
and neurons.39,40  After the isolation of nNOS in the brain, the next isoform that was 
successfully purified was iNOS from a macrophage.41 The final isoform to be purified 
was the eNOS from endothelial cells from a bovine aorta which originally stimulated so 
much of the interest in NO biology and chemistry due to its role in vasodilatation.42 
These three isoforms of NOS are responsible for NO production in different regions of 
the body and are triggered by different factors. The production of NO from each of these 
isoform is identical to the synthetic scheme shown in Figure 1.2. These isoforms are 
found in different cellular hosts, and the cells influence the function that NO serves 
within these cellular regions.  
Figure 1.2: The conversion of L-arginine to L-citrulline by nitric oxide synthase (NOS) 
with the addition of varies cofactors, nicotinamide adenine dinucleotide phosphate 
(NADPH) and oxygen to produce NO in vivo.  
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 The endothelial isofom of NOS is principally responsible for producing NO in 
endothelial cells that line blood vessels. The production of NO in endothelial cells leads 
to smooth muscle relaxation, which allows for blood flow to be regulated throughout the 
body. This isoform of NOS was the first to be discovered allowing researchers to begin to 
understand how endogenous NO was produced.36 This enzyme is not restricted to 
vascular endothelium but has since been found in human neuronal cells, astrocytes, t-
cells, bone marrow cells, osteoblasts and osteoclasts.38 The regulation of eNOS is 
modulated by the phosphorylation, the addition of a phosphate group, and the binding of 
calcium inducing conformational changes to the enzymes structure to initiate NO 
production.38 Additional regulation of eNOS occurs through changes to the shear stress 
within the blood vessel which can also modulate the enzyme’s function.43  
The neuronal isoform of NOS generates small amounts of NO for chemical 
signaling within the central nervous system that is associated with pain perception, 
control of sleep and hunger, and neuronal cell development.  The presence of this isoform 
was first discovered in the brain and since then was found in human lung epithelial cells, 
testis cells and skin cells. As with eNOS, the neuronal isoform is regulated by calmodulin 
and calcium. The production of NO is inhibited when these molecules are not bound to 
the nNOS enzyme.44 
The inducible NOS is responsible for immune responses in organisms and is 
involved in controlling anti-microbial, apoptosis and anti-tumor response as a defense 
against cellular threats. The inducible isoform of NOS, although first isolated in a 
macrophage and associated with immune response, has also been located in human 
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hepatocytes, sinusoidal and endothelial cells.45 Unlike eNOS and nNOS, iNOS is not 
regulated by calcium because of the tight association of calmodulin.  
1.3 Secondary Signaling Pathways of NO 
Some of the biological effects attributed to NO result from secondary signaling 
pathways. The synthesis of NO activated soluble GC increases the production of a 
secondary signaling molecule, cGMP. This secondary messenger molecule that NO is 
linked to was confirmed as GC by a series of experiments preformed in Murad’s 
laboratory between 1976 and 1977.46 Murad et al. connected NO exposure to an increase 
in the activity of GC in various tissues.47 The only known receptor for NO is sGC, which 
governs the conversion of guanosine 5’-triphosphate (GTP) to cGMP.48 Several studies 
using various tissue models summarized in Table 1.1, have demonstrate that NO increase 
the formation of cGMP in various tissues.46





5.8Rat small intestinal muscle
Tissue cGMP Formed(pmol/mg min)
Rat liver 30.5
Bovine lung 32.5
Bovine trachael smooth muscle 33.4
Rat cerebral cortex 20.2
Rat heart 23.1
Rat kidney 18.9
Rat skeletal muscle 13.8
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Understanding secondary signaling pathways is important because they induce 
secondary effects that impact cellular function. As a secondary messenger cGMP induces 
a wide-range of cellular processes through the activation of a kinase cascade, which 
stimulates the cell to regulate the translation or transcription of genes responsible for 
producing various cellular responses. The sGC cylcle has been implemented in many 
cellular processes including vasodilatation, angiogenesis, cellular migration and matrix 
degradation. In the cardiovascular system, for example, NO produces a cascade of 
secondary signaling molecules that leads to vasodilatation and angiogenesis. The binding 
of vasoactive or angiogenic factors to surface receptors on endothelial cell activates the 
synthesis of NO from eNOS and stimulates vasodilatation or angiogenesis. As illustrated 
in Figure 1.3, NO produced by eNOS diffuses from the endothelial cells into smooth 












Figure 1.3: In the cardiovascular system, NO influences many biological 
pathways including inhibiting platelet activation, angiogenesis and vasodilatation 
through smooth muscle relaxation.  
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Another secondary effect caused by the production of NO through the activation 
of soluble GC producing cGMP is angiogenesis. Where the production of cGMP 
stimulates a kinase cascade that results in the transcription of specific genes leading to 
cellular responses that cause angiogenesis.49 Thus, angiogenesis and vasodilatation rely 
on chemical signaling processes that are activated by NO illustrated in Figure 1.3.  
1.4 Nitric Oxide’s Role in Central Nervous System as a Neurotransmitter 
The process of neurotransmission was first proposed by Otto Loewi in 1921, who 
later went on to discover the very first transmitter, acetylcholine. 50 A simple way to 
explain neurotransmission is the process in which neurons communicate through 
electrical and chemical signals to coordinate activity throughout the central nervous 
system.  In general, neurotransmission can be summarized in five steps illustrated in 
Figure 1.4: 1.Synthesis of neurotransmitter 2.Storage of neurotransmitter 3.Release of 
neurotransmitter 4.Receptor binding of neurotransmitter and 5.Inactivation of 










Figure 1.4: A drawing of a synapse between the axon terminal and the postsynaptic 
cell that illustrates all the steps involved in neurotransmission. All important features 
discussed have been labeled.  
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Figure 1.4 shows a cartoon of a synapse between a neuron and a post-synaptic cell, the 
site for neurotransmission or cellular communication. The synapse allows chemical and 
electrical signals to be exchanged stimulating a response from the target cell. Step 1. The 
first step requires that the neurotransmitters must be synthesized within the neuron. The 
necessary enzymes and cofactors must be readily available. Step 2.  Following synthesis, 
the neurotransmitters are stored within a synaptic vesicle that is formed in the presynaptic 
nerve shown in Figure 1.4. Step 3. This vesicle moves the neurotransmitter to the 
presynaptic membrane and releases it following a calcium regulated action potential.  
When these neurotransmitters are released from the presynaptic membrane into the 
synaptic cleft (Figure 1.4) the process is termed exocytosis. Step 4. The neurotransmitters 
locate and bind to membrane bound receptors in the post-synaptic cell (Figure 1.4). There 
are two classes of receptors: metabotropic or ionotropic receptors, which 
neurotransmitters can selectively bind to influence cellular responses within the target 
cell. Metabotropic receptors can influence cellular function through the G proteins (i.e. 
cGMP).  Iontropic receptors control either ion channels that are either gated by a ligand 
or a voltage. Step 5. A termination step is included to allow the nerve to inhibit and 
terminate the neurotransmission. Termination of the signal is accomplished by the 
diffusion, destruction or reuptake of the neurotransmitter. This step is important because 
if transmission continued for sustained periods of time, serious problems could arise from 
tetanus in muscles and seizures in neurons. 
In general, neurotransmitters are classified by their production in the presynaptic 
nerve, followed by their release into the chemical synapse and their binding to a specific 
receptor in the post-synaptic cells.51 Currently there are roughly 100 identified 
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neurotransmitters and each of these transmitters is in one of two categories: excitatory or 
inhibitory transmitters. Excitatory transmitters increase the chances that the transmitter 
will stimulate the nerve to fire an action potential. Inhibitory transmitters suppress nerve 
from firing allowing signaling to be terminated. Several important amino acid 
transmitters are: glutamate, aspartate, glycine and GABA.  
The idea that NO is a neurotransmitter goes against much of the classical 
definition of what constitutes a transmitter. The idea that NO was involved in the 
chemical signaling pathways in the brain was first suggested when NO was found to be 
present in neurons. The release of glutamate from presynaptic nerve terminals acted upon 
NMDA receptors, allowing calcium to enter through gated channels into post-synaptic 
cells.35 The calcium initiated synthesis of NO from nNOS was shown to induce 
vasodilatation and increase in cGMP levels. The role of NO in the brain to regulate and 
influence many cellular processes has allowed some researchers to reason that NO is, in 











NO is known to diffuse through the synaptic cleft and there is evidence that NO 
influences the regulation of many cellular pathways through the activation and 
production of cGMP, an important secondary signaling molecule (Figure 1.5). Although 
it is certain that cGMP is active in modulating cellular activity in the brain, it not 
completely understood the exact functions that are triggered through these secondary 












Nitric oxide was determined to diffuse from the post-synaptic cell and influence 
the pre-synaptic nerve and nearby glial and neuronal cells.52 Nitric oxide also has been 
confirmed to be produced in pre-synaptic and post-synaptic cells.53 This process is 
summarized in a cartoon in Figure 1.5. 




1.5 Nitric Oxide Hypothesized Role in Cell Migration 
  Cellular migration is essential in the development of the nervous system and the 
anatomy of the brain in embryos. These processes require precise movement of cells 
where neurons can travel millimeters or centimeters. Nitric oxide is implicated is in 
neuronal development studies have found strong evidence.54 Gibbs et al. demonstrated 
through in vitro studies that NO and cGMP may be involved in the stabilization of retinal 
growth cone, which provides the foundation for the development of the visual system.55 
Using the olfactory system as a model to study the potential of NO for chemical 
signaling, Roskams et al. were able to show that NO had a prominent role in forming 
connections in developing and regenerating olfactory neurons.56  Another set of in vitro 
studies performed by Kalb et al. support the role of NO in the development of motor 
neurons in rat models.57  
1.6 Classes of NO Donors 
Nitric oxide donors are compounds that store NO in air stable form. Over 15 types 
of NO donor classes exist, allowing researchers to select an NO donor that is appropriate 
to their specific experimental system. These donor classes have been developed to release 
NO based on unique chemistries. As such, specific NO donors can be selected based on 








Below are six common NO donor classes and representative compound from each of 












These featured NO donors are documented in numerous studies looking at the role of NO 
as it applies to the collective understanding of physiological processes.58, 59, 60  In a study 
looking at understanding NO role in development of nerve networks, Wagenen et al. 
demonstrated that the uses of DEA/NO and SNP stimulated the increased the elongation 
of filopodial, cellular branches coming from a central growth cone produced by 
promoting nerve growth in B5 neurons.54 NOR-3 was used to understand NO’s influence 
on apoptosis in human colon cells by varying the NO donor concentration and relating 
apoptosis to an artifact NO through hormone signaling.61 Nitric oxide donor, specifically 
Figure 1.6: Above are 6 molecules each from different classes of NO donors: 
organic nitrates, S-nitrosothiols, organic nitrites, diazeniumdiolates, metal-NO 












































SNP and sodium nitrite, were used to show that NO may contribute to the formation of 
synapses and stimulate neurite out growth.62 Nitroglycerin was used in a study interested 
in understanding NO effect on tumor development in mice models and they found that 
NO release from the NO donor caused a decrease in the growth of tumors through an 
enhancement in cell apoptosis.63 Another study investigated the effect of NO to either 
protect or promote tissue from hydrogen peroxide mediated cytotoxic effects using three 
of the NO donors, DEA/NO, SNP and GSNO.64 Wink et al. found that DEA/NO and 
GSNO protected the fibroblasts from the cytotoxic effects of hydrogen peroxide; 
however, SNP did not protect the cells. An important finding from this work was that the 
concentration of NO could be correlated to the fibroblasts growth.  
These NO donors store and release NO through various mechanisms and an 
understanding of these basic mechanisms is important when choosing the ideal NO donor 
for any application. For example, organic nitrates release NO by a three-electron 
reduction, which can be performed via either an enzymatic or non-enzymatic pathway.59 
Organic nitrites generate NO by a one-electron reduction by hydrolyzing nitrite that then 
is reduced to NO. Metal-NO compound release NO by enzymatic reduction or one 
electron reduction by thiols, hemoproteins. Metal-NO donors are photosensitive and need 
to be protected to keep stable.58 S-nitrosothiols can decompose by thermal, 
photochemical and copper-mediated decomposition.65 Oximes release NO though a 
proposed radical decomposition at basic pH.  Diazeniumdiolates, on the other hand, 
decompose by an acid-catalysed decomposition, and the NO release rate is very 
dependent on pH and temperature.66  
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Diazeniumdiolates have been used extensively because they are bench-top, air 
stable NO donors and yield reproducible NO release profiles at physiological pH with 
variable kinetic rates. The kinetic variability of these diazeniumdiolates was 
demonstrated by Hrabie et al. where they showed that NO release varied with 
temperature and chemical structure of the donor.66  Davies et al. showed that the kinetic 
release of NO from diazeniumdiolates was also pH dependent.67 Diazeniumdiolates have 
also been used to understand NO’s role in biology by mixing into or covalently attaching 
the moiety to polymeric materials. In one example, a small molecule NO donor was used 
in a coating to improve the function of vascular grafts.68,69 In an another study looking at 
killing tumors resistant to other chemotheraphy treatments, Liu et al. demonstrated that 
diazeniumdiolates could be a promising treatment.70 This treatment was successful by 
providing selective release of NO by reacting with a S-transferases in the tumor cells to 
overcome the cells resistances to arsenic and cisplatin.70 In a similar manner, because 
diazeniumdiolates have well-established decomposition kinetics, two diazeniumdiolates 
with different half-lives will be used in this work, MAHMA/NO and DETA/NO. There 
structures and half-lives are shown in Figure 1.7.
Figure 1.7:  The chemical structures of MAHMA/NO (left) and DETA/NO (right) 
are shown above. Both compounds are diazeniumdiolates, a class of NO donors. 


















1.7 Nitric Oxide Detection Methods 
With NO being involved in many biological processes, a need exists for 
quantitative detection methods that can be used to evaluate and understand the role of 
NO. There are two environments that NO measurements are needed: in vivo or in vitro. In
vivo measurements look at quantifying the amount of endogenous NO that is produced in 
different regions of a living organism in order to better understand how NO influences 
cellular behavior within that model. In contrast, in vitro measurements attempt to recreate 
in vivo conditions with cell or tissue models to study NO’s effect in a controlled and 
artificial environment.  
Several detection methods and assays have been developed to assess NO 
concentrations directly and indirectly through decomposition products or secondary 
products (nitrosyl, nitrite, cGMP). Direct detection of NO is important to ensure NO is 
indeed detected and not a secondary product NxOy. In many cases, these direct methods 
are used when studying and quantifying NO in more fundamental systems.  In more 
complex systems such as cell and tissue models, many still quantify NO using assays that 
monitor byproducts to estimate the amount of NO in the system.  
Electrochemical Detection 
The most commonly employed direct NO measurement technique is 
electrochemical detection. One of the major reasons for this is that electrochemical 
detection has extremely low detection limits. For example, in 1990, Shibuki and 
coworkers, developed an electrochemical microprobe, 150- 200 m in diameter that was 
inserted into a 400 m cerebellar rat slice followed by electrical stimulation of the tissue 
resulting in an observed NO concentration ranging between 8 and 58 nM.71 A later study 
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using similar electrochemical probes on 400 m auditory cortex brain slices that were 
electrically stimulated found NO release in 380±14 pM.72 Building off the work done 
previously by the Shibuki group, a platinized carbon fiber microelectrode with a 5-7 m 
diameter was used to establish a maximum local concentration of NO of 1.8±0.2 M at 
10 to 30 m depth in rat cerebellar tissue slice after a 5 min stimulation in a 100 M bath 
of N-methyl D-aspartate (NMDA).73 From these various studies using electrochemical 
detection, a dynamic range of 1800 to 0.38 nM has been established for the expected 
range for physiological release of NO in brain tissue.74 
Since electrochemical detection of NO is more common, many different 
approaches exist to electrochemically detect NO and the electrode design. These different 
approaches come with certain inherent strengths and weaknesses. The basic principle 
behind electrochemical detection is that a negative or positive potential is applied to the 
electrode and then the electrode reduces or oxidizes an electrochemically active species, 
which produces a current that is proportional to that species concentration.  The most 
common electrochemical technique for measuring NO is amperometry, which allows 
users to quickly collect low current outputs at a fixed potential.  The fast response time 
makes this type of electrochemical detection ideal for biological systems. Other 
electrochemical detection methods have been used to monitor NO; however, for the 
purpose of this overview, only amperometric systems will be discussed.8 Since there are 
two types of potentials used in amperometric systems, there are two strategies for 
measuring NO directly at an electrode.  
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Reduction of NO at an electrode can occur via a 2 electron, shown in Figure 1.8, at 
negative potential ranging from -0.5 to -1.4 volts compared to a Ag/AgCl reference 
electrode.75  




Electrochemical reduction of NO is a less frequently used approach for detecting NO 
because these systems tend to have lower sensitivity, slower scan rates, oxygen 
interferences, and difficulty in detecting at physiological pH.76 A major challenge with 
detection of NO at negative potentials is the influence of oxygen on the signal because 
the standard reduction potential for oxygen is -1.229 V with respect to the standard 
hydrogen electrode.77 Thus, to monitor NO effectively, the oxygen interference must be 
successfully subtracted out to achieve an accurate NO detection reading. 
Because of the challenges associated with reductive electrochemical detection of 
NO, is another approach to detect NO is through the oxidation of NO, accomplished in 3 
steps at positive potential as shown in Figure 1.9. 
NO NO e
NO OH HNO2




When using positive potential to measure NO, concern exists that nitrite is produced in 
the final step may of the oxidation and may give a false high signal. As such, researchers 
need to be careful when selecting a potential, where only NO is detected. This is 
Figure 1.8: An expression for the 2 electron reduction of NO at negative 
potential in electro-reduction detection systems for NO.
Figure 1.9: An expression for the 3 electron oxidation of NO at positive potential 
in electro-oxidation detection systems for NO.
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especially the case in biological applications where the potential for other sources of 
nitrite to be present or formed through various side-reactions is real.78 This is only one of 
the limitations that need to be overcome to improve electrochemical detection of NO as 
there are several other species that can interfere with the NO signal. Depending on the 
electrochemical system used to monitor NO several factors are involved with limiting the 
influence of interferences: sensor type, active potential, type of selective membrane and 
biological environment.79  Several common species that interfere with the 
electrochemical detection of NO are highlighted in Table 1.2. 
Table 1.2: Common Biological Interferences in Electrochemical Detection of NO79 
 
In order to improve the overall selectivity of electrochemical detection and minimize 
some of these interferences, one common strategy employed is to coat the electrode 
surface with a selective membrane, like nafion.  Nafion is used to minimize NO 
conversion into byproducts (i.e. nitrite) from being produced by stabilizing the forming 
NO+ species within the membrane. Nafion can selectively repealing anionic interfering 
0.28 - 1.14 μMSerotonin
0.35 - 2.96 nMNorepinephrine
< 2.0 nMDopamine
66 - 199 μMAcetaminophen
150 - 470 μMUric Acid
34 - 144 μMAscorbic Acid
< 20 μMNitrite
5.88 - 23.10 nM3,4-dihydroxyphenylacetic acid(DOPAC)
0.5 - 1.5 μMCarbon Monoxide




species making it advantageous for use to minimize nitrite, but cannot minimize cationic 
interferences such as dopamine.
Electron Paramagnetic Resonance 
 
 Electron paramagnetic resonance (EPR) is another direct detection method that 
has been successfully used to monitor NO in biological systems. This technique has 
proven useful in measuring NO directly in living tissues and organs.80 This technique is 
frequently used to understand the complex binding phenomena between NO and the 
heme group in hemoglobin.81  
This technique is used to monitor any paramagnetic radical species, which has 
unpaired electrons that can be promoted to higher energy levels by a required amount of 
microwave frequency.82 The basic idea behind EPR detection is that the unpaired  
orbital electron is excited by a microwave frequency that excites the electron into higher 
energy levels and as that electron relaxes a unique signal is emitted. However, this 
simplistic explanation of EPR is not how NO is monitored via EPR because the electron 
that is excited in NO radicals has a relaxation time which is much too fast to detect. NO 
is studied using a technique called spin trapping. Spin trapping allows for the complete 
conversion of NO into a more stable radical that allows the characteristic EPR signal to 
be recorded (Figure 1.10).    
 




Figure 1.10: An expression explaining how NO or any radical of interest (R*) is 
trapped by reacting with a species (ST) that traps the radical quickly to create a 
more stable radical trap addict (R*-SA). 
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Spin trapping, in principal, seems straightforward; however, in practice, it has been far 
more challenging to implement since spin trap molecules are not radical species, thus not 
detectable via EPR. There are two prominent spin trap molecules used extensively in the 
literature to look at NO by EPR detection. These molecules are hemoglobin, an excellent 
endogenous spin trap and iron-dithiocarbamates, an exogenous spin trap used in many 
studies.  The EPR signal is generated from the relaxation on an excited electron in that 
moment the energy difference between the two possible signs (Ms  ½) is equal to 
microwave energy.83 EPR signal gives researchers specific information about interactions 
of unpaired electrons.  Hyperfine and superfine spectral features can be used to confirm 
spectra origin from electron spin coupling as in nuclear magnetic resonance.84
There are some inherent advantages for using EPR in vivo systems since tissue 
and biological systems often contain a spin trapping agent, such as hemoglobin (Hb). An 
added benefit to NO detection with Hb, is that EPR selectivity favors Hb-NO 
(paramagnetic) over Hb-O2 and Hb-CO2 (diamagnetic). The paramagnetic specificity has 
eliminated inflation in signal from possible sources of interferences in nitrite and nitrate. 
The overall sensitivity of EPR suffers because of the broad range of magnetic field 
strength used to initiate an EPR signal; however, to some degree this can be compensated 
by performing EPR studies at low temperature.84 Sensitivity may interfere with collecting 
measurements that must be performed at physiological conditions. Using iron-
dithiocarbamate spin trapping agent, EPR has a detection limit of ~6 pmol for NO.85 
The underlying theory behind EPR detection of NO is based on quantum 
mechanics. Therefore the use of conventional and advanced EPR is very complex and 
data analysis can be challenging especially when identifying spin interaction represented 
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by the appearance of hyperfine and superfine structure on spectra. This detection system 
has allowed researcher to learn novel insights to deepen the collective understanding of 
NO’s role in biology with the ability to make qualitative and quantitative measurements 
of NO. This system is not well suited for developing a straight forward and streamlined 
measurement method for detecting NO release from NO donor in cellular media buffered 
by carbon dioxide. 
Chemiluminescence
  The final direct detection technique for NO is chemiluminescence. 
Chemiluminescence has been used to produce reliable NO release profile for a variety of 
NO donor and NO releasing polymeric materials.86,87,68,88 The ozone chemiluminescence 
method is a sensitive technique that allows for detection of NO in real time and total 
recovery of NO that is introduced to the system. This technique works by reacting 
gaseous NO with ozone, formed in the instrument, to create an excited state nitrogen 







The amount of light that is generated can then be directly related to the concentration of 
NO by a calibration constant determined by the reduction of nitrite to NO by 
hydrosulfuric acid and confirmed using any NO donor. Detection of any light is directly 
tied to the relase of NO eliminating the potential for interference. The detection limits for 
ozone chemiluminescence detection system is reported to be ~10 pmol, making this an 
excellent technique to look at physiological levels of NO.90  
Figure 1.11: An expression explaining how NO is detected using chemiluminescence. 
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Although chemiluminescence is an excellent technique to monitor NO, the 
technique requires that the system be deoxygenated, making in vivo studies challenging. 
However, this system is very beneficial for the development of a bench-top, real-time 
measurement method to analyze NO release from commonly used NO donor in 
conditions that mimic those used in in vitro studies to gauge NO’s cellular influence.
NO detection in Cell and Tissue media 
Literature precedent for a bench-top cell media-based detection system for NO, 
nitrite and nitrate was published by Ridnour et al., where they used an indirect 
spectroscopic assay to approximate the amount of NO, nitrite and nitrate.91 Based on 
shifting the pH, they claimed to resolve the approximate the concentration of NO, nitrite 
and nitrate in 10% cell media buffered by 90% PBS (pH 7.40).91 This experiment is a 
great example of how many cell and tissue models are analyzed for apparent NO. 
However, Ridnour’s system lacks three essential requirements for measuring NO in tissue 
media. The first is direct detection of NO that eliminates false positive signals from NxOy 
species. The other important features lacking in this method include the ability to 
measure NO release in real time and to use full strength tissue media buffered by CO2.  
There have been reports of electrochemical detection of NO in tissue media.92 
However, many of these in vitro NO detection experiments employ 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) or tris(hydroxymethyl)aminomethane (TRIS) 




Nitric oxide has a significant role in biological system. Researchers now 
understand how NO is produced in vivo and that most of the cellular responses are 
regulated through the secondary signaling molecule, cGMP. In order to begin to use this 
knowledge to combat diseases and disorders that can be linked to NO deficiencies, 
additional analytical detection methods are needed to be able to accurately monitor NO 
concentrations.  As previously discussed, several NO measurement methods exist, but 
limited methods are available that allow for detection under conditions commonly used in 
in vitro cell and tissue model studies, specifically where the medias is buffered by carbon 
dioxide.  
 In this thesis, I will present a measurement method developed to measure 
physiological levels of NO from NO donors in a bench-top system equipped to mimic 
conditions used in cell and tissue studies. This method will aim to demonstrate 1) 
detection of NO from a 10-7 M NO donor (MAHMA/NO) in phosphate buffered saline 
(PBS) and 2) detection of NO release from NO donors (MAHMA/NO and DETA/NO) in 
tissue media buffered by CO2. The first aim focuses on modifying the current 
chemiluminescence methodology for NO donor concentrations from 10-4 M to 10-7 M 
enabling this measurement method to monitor a wider range of NO donor concentrations. 
The significant of this method development will be to allow researcher to measure 
accurate NO releases profile for a wide range of NO donor concentration that could be 
used in therapeutic applications. The second aim focuses on developing an accurate NO 
release measurement method that will allow NO donors to be studied in buffered tissue 
media. Tissue media buffered by CO2 is used frequently in many biologically relevant 
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experiments looking at the effect of NO. However, current methods typically use PBS 
since the buffer can be set to physiological conditions (37 C, pH 7.40). This buffering 
system is not used in cell and tissue model experiments because it does not contain the 
necessary nutrients required to artificially sustain the cells. Tissue media, which contains 
over 25 essential elements, is typically buffered with CO2 gas to maintain the pH at 7.40 
by employing a carbonic acid and bicarbonate buffering system.  
Figure 1.12 shows a flow chart, which outlines the design of separate experiments 




The first step is to measure NO release from the decomposition of NO donor and 
calculate the donor decomposition half-lives. Three main factors will be used to establish 
the measurement method effective: accurate donor release kinetics, total NO recovery 
and ability to maintain pH 7.4 and 37 C. The rationale for this approach was to begin in 
a simple model system and show that the decomposition of MAHMA/NO can be 
Figure 1.12: Flow chart showing the experimental development of custom 
method based on MAHMA/NO decomposition.
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monitored by NO release. Once the measurement method is functioning at the 2 mL 
volume, slight incremental changes to the volume can be made to the method. As the 
volume increases the total NO recovery and accurate donor decomposition half-lives was 
achieved by adjusting the gas regulation. The increase in buffer volume will allow for 
more dilute NO donor solutions to be monitored with this chemiluminescence 
measurement method. Once the method could reliably achieve complete NO recovery 
and accurate donor decomposition half-lives the method could be expanded from a 
simplistic buffer system to tissue media buffered by 5% CO2. This measurement method 
can be used to measure NO release profile from NO donor at lower concentrations and 
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2. METHOD DEVELOPMENT FOR MEASURING NO RELEASE FROM DILUTE 
NO DONOR SOLUTIONS  
2.1 Introduction
 Although the exact physiological concentration of nitric oxide (NO) for a variety 
of functions in vivo is still unknown, in vivo concentrations of 100 pM -1 M have been 
reported.1 Nitric oxide donors have been used in a variety of studies to better understand 
the role of NO in physiology.2,3 In order to release NO within this physiological range, 
NO donors have been used at various concentrations to release NO that can influence 
cellular response in vitro studies.2, 3,4 Several detections methods are commonly 
employed to accurately measure NO release from NO donor concentrations; in general, 
spectroscopic (10-3 M), electrochemical (10-6 M) and chemiluminescence (10-4 M) 
analysis have all been demonstrated. However, electrochemical methods have the ability 
to monitor NO release from a wider range of NO donor concentration than other 
techniques. Because NO donors are being explored as potential NO therapeutics and used 
in vitro studies to assess NO’s influence in physiology, there is a need for the 
development of reliable analytical methods that allow researchers to measure accurate 
NO release profiles for a range of NO donor concentrations. These new methods will 
allow researchers to explore the full possibilities of using synthetic NO donors as 
potential therapeutic compounds to treat various illnesses and disorders.  
In this chapter, I will demonstrate a significant improvement in the ability to 
measure NO release from a wider concentration range of the NO donor, 
Methylaminehexylmethylamine diazeniumdiolate (MAHMA/NO) through the 
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modification of a chemiluminescence based method to monitor NO release from 10-4 M 
to 10-7 M MAHMA/NO solutions. 
2.2 Materials
Sulfuric acid (H2SO4, BDH), potassium iodide (KI, Fisher Scientific, 99.1%), 
sodium hydroxide (NaOH, Fisher Scientific, 99.8%), hydrochloric acid (HCl, BDH), 
phosphate buffered saline pressed tablets (PBS, EMD, 80-85% sodium chloride, 10-15% 
sodium phosphate [dibasic], 1-5% potassium chloride, 1-5% potassium phosphate 
[monobasic]) and sodium nitrite (Alfa Aesar, 99.999%) were purchased commercially 
and used as received. Methylaminehexylmethylamine (MAHMA, TCI America, 97%), 3 
Å molecular sieves (Acros Organic, 8 to 12 mesh) and acetonitrile (CH3CN, Sigma 
Aldrich, 99.5%) were purchased commercially and used to synthesis MAHMA/NO. 
MAHMA/NO was synthesized and purified in house following a detailed description 
described in section 2.3.1. All aqueous solutions were prepared using Millipore treated 
water (18.2 M ). Nitrogen (Ultra High Grade Purity) and oxygen (Medical grade) 
compressed gases for NO release measurements were purchased from Air Gas. The 45 
ppm NO cylinder (Air Liquide, 98%) was used for daily calibration and ultra-high purity 
NO (Air Liquide, 99%) was used for NO donor synthesis. 
2.3 Methods 
2.3.1 Nitric Oxide Donor Synthesis 
MAHMA/NO was prepared according to a previously published report by 
reacting the methylaminehexylmethylamine with NO at 80 psi in dry acetonitrile for 24 
h.5 Acetonitrile was dried over 3 Å molecular sieves prior to use. The solid white product 
was filtered off and washed with dry CH3CN and dried under vacuum for approximately 
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three hours. The diazeniumdiolate was characterized for purity by UV spectroscopy at 
250 nm and then stored in a -5 °C freezer until use. 
2.3.2 Nitric Oxide Release Measurements 
Nitric oxide measurements were performed using a Sievers Nitric Oxide Analyzer 
(NOA), model 280i.  The instrumental sampling rate was set to 200 mL/min with a cell 
pressure ranging from 6.5 to 9.8 Torr and the oxygen supply pressure ranged from 4.2 to 
6.9 psig.  
Nitric Oxide Release 10-4 M MAHMA/NO Experiments in 2 mL 
The initial protocol for the MAHMA/NO decomposition experiments were based 
on spectroscopic MAHMA/NO decomposition and NO release experiments previously 
published by Davies et al and Reynolds et al.6,7 The NO donor stock solution for 
MAHMA/NO was prepared in 0.1 M NaOH and the concentration was confirmed by UV 
spectroscopy (250 nm). The bubbler gas was set to 16 mL/min rate and the flow gas was 
set at 184 mL/min, offsetting the 200 mL/min sampling rate to the detector. The NOA 
instrument’s data collection interval was set to 1 s.   The NOA instrument was calibrated 
daily with nitrogen (zero gas) and a 45 ppm NO standard.  The sample cell was filled 
with 2 mL of PBS buffer at pH ~7.15 and the cell was sealed and hooked up to the 
bubble, flow and vacuum lines. The sample cell was degassed and then a baseline was 
collected. A calibrated syringe was used to inject 20 l of the MAHMA/NO stock 
solution into the sample cell. Once the signal returned to a baseline reading, data 
collection was terminated and a final pH reading was recorded for the sample. This 
experiment was repeated 5 times in order to achieve reproducibly MAHMA/NO 
decomposition kinetics at this volume. Data analysis was performed in Excel and a 
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detailed protocol for how to process NO release data to elucidate MAHMA/NO half-lives 
is described below.
Nitric Oxide Release 10-4 M MAHMA/NO Experiments in 6, 8 and 10 mL 
Nitric oxide release measurements were carried out similarly to the 2 mL 10-4 M 
MAHMA/NO experiments discussed previously, with variations to the injection volume 
and gas regulation for the increase in buffer volume in the 6, 8, and 10 mL case. In the 6 
mL case, the bubbler gas was increased to 35 mL/min and then the flow gas was 
decreased to 173 mL/min to offset the 200 mL/min sampling rate of the vacuum with an 
injection volume of 60 l. In the 8 mL case, the bubbler gas was set to 43 mL/min and 
the flow gas was set to 156 mL/min. An injection volume of 80 l of the MAHMA/NO 
stock solution was used. In the 10 mL case using the custom 3-port NOA sample cell, the 
bubbler gas was set to 59 mL/min and the flow gas was set to 140 mL/min. An injection 
volume of 100 l of the MAHMA/NO stock solution was used. 
Nitric Oxide Release 10-7 M MAHMA/NO Experiments in 10 mL 
Nitric oxide release measurements were performed similar to all other 
MAHMA/NO experiments discussed previously with a few modification to the injection 
volume and gas regulation settings. In order to perform the 4.4 x 10-7 M experiments 
using the 3-port NOA cell, a MAHMA/NO donor stock was determined to be 4.4 x 10-5 
M by UV analysis and the bubble gas was set to 46 mL/min and the flow gas was set to 
156 mL/min with an injection volume of 100 l. A 100 l of the MAHMA/NO stock 




MAHMA/NO decomposition data was processed using Excel. The raw NO 
release data was first uniformly converted into part per billion responses (PPB) and the 
NO release profiles were plotted as NO release in PPB versus time. The NOA instrument 
calibration constant was used to convert its output signal to moles of NO. In order to 
calculate experimentally derived MAHMA/NO half-lives, moles of NO is converted to 
[MAHMA/NO]decomp and finally into ln([MAHMA/NO]decomp). Rate constants were 
determined by the slope of the linear regression applied to the ln([MAHMA/NO]decomp) 
versus time graph.   
In order to determine the half-life for MAHMA/NO decomposition in PBS, the 
rate constant determination plots were plotted in terms of percent MAHMA/NO 
decomposition from 60% to 20% ln([MAHMA/NO]decomp) versus time to achieve a linear 
fit with an R2 of 0.999. 
 Statistical analysis of all experimental data were performed by applying a t-test at 
the 95% confidence level and comparing its result to the literature value of 60 s to the 
MAHMA/NO half-life’s determined in the 2 mL experiments. All t-tests were performed 
assuming equal variance and this assumption was validated by a f-test at the 95% 
confidence level.  
2.4 Results 
2.4.1 Current State of Chemiluminescence Methodology  
The use of chemiluminescence to analysis the NO release from NO donors and 
NO releasing polymeric materials is routinely done in PBS buffer at pH 7.40 and           
37 ºC.8,9,7,10 Typically, NO release measurements are performed in 2 mL PBS (pH 7.40) 
41 
 
within a custom 2-port sample cell that is deoxygenated prior to NO donor injection. The 
nitrogen gas is controlled by a gas regulation system that is set to have a bubbler rate of 
16 mL/min and a flow rate of 184 mL/min to offset the sampling rate of the headspace 
for NO at 200 mL/min. Detection of NO occurs within the chemiluminescence chamber, 
where the NO gas is reacted with ozone. The NO and the ozone gas reacts to creates 
excited state nitrogen dioxide (NO2*) species that when these species relaxes back to the 
ground state they generate photons. These photons are amplified by the photo multiplier 
tube, a millivolt response is then measured by a plot computer program. The data is 















The experimental set-up for measuring NO is shown in Figure 2.1 and features a custom 
sample cell, a gas regulation system and a gas removal port that leads to the 
chemiluminescence detector in the NOA instrument.  
 
2.4.2 Chemiluminescence MAHMA/NO Decomposition Studies at 10-4 M in 2 mL
To fully assess NO potential role in cell and tissue studies, an NO release 
measurement method is needed, that is capable of measuring the NO release from a wide 
range of NO donor concentrations. In these studies, MAHMA/NO will be used as the 
Figure 2.1: A diagram of the NO release measurement set-up with bubble and flow 
gas entrances (gas regulation), the injection port (sample) and gas removal port 
(reaction chamber) all labeled.  
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model NO donor. Using a spectroscopic method, MAHMA/NO decomposition has been 




The MAHMA/NO decomposition in aqueous environment is shown in Figure 2.3, which 
produces 2 moles of NO and 1 mole MAHMA. The rate of the reaction, k= 0.0116, has 
been well-documented in the literature to correspond to a half –life of 60 s for the 





This reaction will be used to ensure that the method developed is consistent with the 
previously reported behavior for MAHMA/NO. The reaction shown in Figure 2.3, gives 
three important factors to gauge the success of this method development: accurate 
MAHMA/NO half-life, complete NO recovery and standardized reaction conditions (pH 
7.4, 37 C). In this work, MAHMA/NO will used as a model NO donor, to develop a 
measurement method that allows for detection of NO from lower NO donor concentration 
than previously reported. 
In order to demonstrate that this method is performing properly, three factors have 
been identified to gauge the performance of this methodology. The first factor is accurate 
Figure 2.3:  The decomposition reaction for MAHMA/NO in aqueous solution at 
pH 7.4, 37 C. Based on literature precedent, the rate of reaction has been 
documented to be k= 0.0116 giving a 60 s half-life for MAHMA/NO. 




MAHMA/NO half-lives to ensure that NO release from MAHMA/NO decomposition is 
first order and has a half-life of 60 s.12,6 The second factor is obtaining complete NO 
recovery (100%). The term NO recovery, refers to the experimental total moles of NO 
divided by the theoretical moles of NO injected and times by 100. This ensures that the 
total amount of MAHMA/NO injected into the system is proportional to the amount of 
NO recovered based on 1 mol MAHMA/NO yields 2 mol of NO. Finally, the 
experimental conditions were standardized to pH 7.40 and 37 C. Keeping the 
experimental condition consistent was essential to this methodology because both 
temperature and pH have been shown to influence the decomposition kinetics of 
diazeniumdiolates.6,5  
MAHMA/NO decomposition studies were performed in PBS buffer by measuring 
NO release with a chemiluminescence detector. The use of chemiluminescence to 
measure NO release profiles to obtain accurate NO donor kinetics was previously 
demonstrated with diazeniumdiolates in PBS by Reynolds et al.13 Figure 2.4A shows the 
NO release from MAHMA/NO that is characteristic of its decomposition and consistent 
with previously reported MAHMA/NO decomposition at pH 7.40 and 37 C. The NO 
release profile shown in Figure 2.4A can be used to calculate the decomposition rate 
constant based on first order mechanism where the natural log transformation of 
[MAHMA/NO]decomp  as a function of time is shown in Figure 2.4B. A percent donor 
decomposition interval (i.e. 60-20%) was applied to eliminate the influence of NO donor 
mixing at the time of injection until an equilibrium was established and for pH 
equilibration following the injection of the NO donor in basic solution. The percent donor 
decomposition interval also increased the linear fit of the trend line applied to calculate 
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the rate constant for MAHMA/NO decomposition. The half-life of MAHMA/NO 
calculated using Figure 2.4B yields a half-life of 63±2 s for MAHMA/NO in 2 mL PBS. 
When compared to the literature value at the 95% confidence interval, it was determined 
that the experimentally-derived half-lives are within the same sample population as the 
literature value (60 s). The second qualifier called NO recovery percent was found to be 
98±3 demonstrating that the entire NO released from MAHMA/NO was recovered. The 
third factor was the experimental conditions and the pH was confirmed to pH 7.42±0.02 
and the water bath held the buffer at 37 C. Based on all three factors, the measurement 
method was determined to be functioning properly for determining accurate 





2.4.3 Chemiluminescence MAHMA/NO Decomposition Studies at 10-4 M in 6, 8 and
10 mL 
Although accurate MAHMA/NO half-lives and complete NO recovery were 
obtained using this measurement method for 10-4 M AHMA/NO in 2 mL PBS, the 
method needed two additional modifications to improve the detection of NO at lower 
Figure 2.4: Typical NO release profile for MAHMA/NO decomposition (A, 
left). NO release measurements were converted into ln([MAHMA/NO]decomp) 




concentrations of NO donor. The first modification involved increasing the volume of 
PBS buffer within the sample cell incrementally, and the second involved adjusting the 
bubbler gas rate using the gas regulation system to achieve total NO recovery and 
accurate MAHMA/NO half-lives. 
After increasing the volume to 6 mL from 2 mL, it was found that the time to 
recover NO released from a 10-4 M MAHMA/NO increased significantly and the 
experimentally derived MAHMA/NO half-life appeared to slow down. This indicated 
that there were some potential issues that were preventing accurate MAHMA/NO half-
lives from being calculated: 1) donor impurities, 2) donor complexation, 3) change in pH, 
and or 4) NO trapping in the buffer volume. MAHMA/NO purity was assessed and 
validated as pure because of a clean UV spectroscopic profile centered at a max of 250 
nm and ±10% of 100% NO recovery. Donor complexation could be eliminated since 
MAHMA/NO kinetics were successfully produced in PBS in the literature and in the 2 
mL 10-4 M MAHMA/NO studies as discussed in section 2.4.2.6 Changes in pH were 
discounted because pH was measured before and after each NO release experiment 
confirming a pH of 7.40. The “apparent” increase in MAHMA/NO half-life was 
attributed to a large amount of NO remaining in the solution as the buffer volume was 
increased. An increase in the amount of NO in the buffer volume would lead to 






Figure 2.5 gives a visual representation of this explanation where the amount of soluble 










The bubbler rate of 16 mL/min could efficiently purge trapped NO in the 2 mL case; 
however, the same 16 mL/min bubbler rate was not effective in purging all the trapped 
NO in large volume studies. As a result as the PBS buffer volume increased within the 
sample cell, the percent NO recovery for MAHMA/NO would decrease and the half-life 
would artificially increase, suggesting that indeed the NO gas was being trapped in the 
buffer. To overcome this, the bubbler gas rate was increased to expel the NO gas trapped 
within the buffer. As a result, in the 6 mL case the bubbler rate was increased to 35 
mL/min to purge NO from the solution into the headspace. By increasing the bubbler rate 
in larger buffer volume experiments, accurate MAHMA/NO half-lives could be achieved 
that were similar to those exhibited in the 2 mL volume system discussed in section 2.4.2. 
Thus, the second modification involved adjusting the bubble gas rate to offset the 
increase in buffer volume.  
Figure 2.5:  As the buffer volume increase from 2 mL to 6 mL the increase in 
volume allows more NO to be soluble in the buffer, trapping NO and 
artificially slowing the experimentally derived MAHMA/NO half-lives. 
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In order to understand how the bubbler gas rate was adjusted to yield accurate 
MAHMA/NO half-lives and complete NO recovery, the gas regulation system will be 
explained briefly. The gas regulation system controls both the bubbler gas rate and the 
flow gas rate by using two calibrated flow meter to control both gas rates into the sample 
cell. This allows for the bubbler and flow gas rates to be balanced to the instrumental 
sampling rate of 200 mL/min, the amount of gas pulled from the headspace by a vacuum 
in the NOA. The flow meters were used as shown in Figure 2.2 and were calibrated from 
0 to 75.5 mL/min ( 1.51 mL/min) [size 1] and 0 to 827.0 mL/min ( 16.54 mL/min) [size 
2]. The bubbler gas rate was regulated by a size 1 flow meter and the flow gas was 
regulated by a size 2 flow meter. Each flow meter is calibrated to relate a mL/min rate of 
gas to a millimeter scale as detailed in Table 2.1. 














After initial experiments at 2 mL 10-4 M MAHMA/NO, studies demonstrated that 
MAHMA/NO half-lives could be derived reliably from NO release measurements at a 
donor concentration of 10-4 M.  The methodology was extended to enable an NO donor 
concentration of 10-4 M at 6, 8 and 10 mL buffer volume. As shown in Table 2.2, by 
increasing the bubbler gas rate for all the volume studies greater than 2 mL complete NO 
recovery and accurate MAHMA/NO half-lives were achieved. For 6 mL studies, the 
bubbler gas was increased to 35 mL/min and experimentally derived half-life for 
MAHMA/NO was calculated to be 65±2 with an 88±2 percent NO recovery. Again by 
increasing the bubbler gas to 43 mL/min and 59 mL/min in the 8 mL and 10 mL cases, 
MAHMA/NO half-lives of 63±2 and 67±9 were calculated with a percent NO recovery 
of 90±2 and 82±2. By adjusting the bubbler gas rate, both quantitative NO recovery and 
accurate MAHMA/NO half-lives were achieved in these volume studies.  






                                                 
1  The NO percent recovery, rate constants, half-life and final pH values shown in table are the average 






















2 16 184 7.42±0.02
6 35 173 7.42±0.01
8 43 156 7.40±0.03











In order to verify that these experimentally derived half-lives for MAHMA/NO 
are accurate, they were compared to the literature value previously reported for 
MAHMA/NO. A comparison of the literature value and the experimentally-derived 
MAHMA/NO half-lives at different volumes of buffer are summarized in Figure 2.6.  
Specifically, Figure 2.6 compared the literature value (60 s) to the experimental half-lives 
calculated for MAHMA/NO at different volumes: 63±2 (2 mL), 65±2 (6 mL), 63±4 (8 
mL) and 67±9 (10 mL). Together, Table 2.2 and Figure 2.6 is evidence of a well 
characterized NO measurement method at various volumes of PBS buffer for 10-4 M NO 
donor concentrations. The experimental conditions at various volumes were adjusted to 
achieve the same percent NO recovery and accurate MAHMA/NO half-lives as 
previously demonstrated in the 2 mL 10-4 M MAHMA/NO decomposition experiments in 
section 2.4.2. This assertion has been confirmed through statistical analysis at the 95 % 
confidence interval comparing the experimentally derived MAHMA/NO decomposition 
half-lives at the 6, 8 and 10 mL buffer volumes to the experimentally derived 
MAHMA/NO decomposition half-lives for MAHMA/NO at the 2 mL volume. At the 95 
Figure 2.6: Experimental half-lives for MAHMA/NO at different volumes of 
PBS buffer relative to the literature value for MAHMA/NO, 60 s (solid line).   
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% confidence interval, it was determined that all of the experimental half-lives are within 
the same population and are consistent with the reported value for MAHMA/NO. These 
experimental results (Figure 2.6 & Table 2.2) and the statistical analysis demonstrates a 
measurement method that can obtained accurate MAHMA/NO half-lives and complete 










Further, a comparison of total NO release and buffer volume will be used to 
determine a relationship between NO release and volume. Figure 2.5 shows a graph that 
plots the total average moles of NO released from a 11 mM MAHMA/NO stock with 
respect to different volume of buffer in the sample cell. In these experiments, the buffer 
volume and the injection volume increase linearly from 20 l in 2 mL to 100 l in 10 
mL. The linear fit demonstrates that the average moles of NO increase linearly with 
injection volume and buffer volume with a R2 of 0.9936. As evident in Figure 2.5, the 
linearity between the moles of NO released and volume of buffer was confirmed. Since a 
linear relationship was established between the average NO release and the buffer 
Average NO Release Compared to Buffer Volume 
Figure 2.7: The graph shows the average moles of NO released at five different 
volume of PBS using an 11 mM MAHMA/NO stock. Using a linear regression, 
the data was fitted achieving a linear fit of R2 = 0.9936. 
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volume, the MAHMA/NO half-lives measured at different volumes of buffer could now 
be compared to each other. The establishment of this relationship between NO release 
and volume is important for comparing the resultant experimental half-lives to the 
optimized 2 mL system and to the MAHMA/NO half-life previously reported in the 
literature.  
2.4.4 Chemiluminescence MAHMA/NO Decomposition Studies at 10-7 M in 10 mL 
This section describes NO measurements from 10-7 M MAHMA/NO. Using the 
10 mL buffer system, a 100 l aliquot of the MAHMA/NO stock solution was injected 
into the sample cell. As shown in Figure 2.8A, the NO release profile shows an 
exponential decay characteristic of the spontaneous decomposition of MAHMA/NO. 
Since the MAHMA/NO concentration is much more dilute than the 10-4 M studies the 







Figure 2.8: Even at more dilute concentration of NO donor, the NO release 
profile for MAHMA/NO decomposition is conserved although short lived at 500s 
(left, A). The rate constant determination graph shows rate constant 
determination using first order kinetics to obtain accurate MAHMA/NO half-
lives (right, B).  
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Further, the MAHMA/NO half-lives determined from a 4.4x10-7 M MAHMA/NO donor 
concentration were calculated to be 66±2 with 117±2 NO recovery. The 19% derivation 
from theoretical NO recovery, is similar to the standard deviation experienced in the 10-4 
M studies. Statistical analysis was performed at the 95% confidence interval to confirm 
that these experimentally derived half-lives were within the same population as the 
literature value for MAHMA/NO. This confirms that through system refinement and 
modification of the bubbling rates accurate MAHMA/NO decomposition half-lives were 
achieved and that they were statistically similar to the literature values for MAHMA/NO 
at the 95% confidence interval. This experiment demonstrates how valuable this new 
methodology can be for the analysis of NO release from dilute concentration of NO 
donors because prior chemiluminescence methodology allowed for routine analysis of 
NO release from 10-4 M donor concentrations, now using this methodology the 
concentration range was extended to 10-7 M MAHMA/NO. 
Because of the development of the data processing protocol, this method is able to 
analyze NO release profiles to obtain accurate MAHMA/NO half-lives from 10-4 M and 









Figure 2.9 shows a direct comparison in terms of NO release (mol NO) between the 10-4 








Using the percent decomposition of 60%-20%, this method is able to generate accurate 
MAHMA/NO decomposition half-lives for a range of 10-4 to 10-7 M MAHMA/NO 
concentrations. Prior to the development of this methodology, 10-7 M MAHMA/NO 
could not be measured using standard chemiluminescence measurement method. 
2.5 Conclusions 
To conclude, the specific aim of this work was to extend the range NO donor 
concentrations that could be monitored with chemiluminescence. This methodology was 
developed using MAHMA/NO at 10-4 M that yielded accurate MAHMA/NO 
decomposition half-lives and complete NO percent recovery at pH 7.40 at 37 C. 
Increasing the volume in the sample cell and altering the bubbling gas rate were crucial to 
monitor NO release from these dilute NO donor concentrations. These modifications 
allowed for the analysis of a 4.4x10-7 M MAHMA/NO donor concentration, which could 
not be measured previously using other chemiluminescence methods.
A. B.
Figure 2.9: A direct comparison of the NO release profiles (moles NO) for the 10-4 M 
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3. MEASUREMENT METHOD TO QUANTIFY NO RELEASE FROM NO DONORS 
IN CARBON DIOXIDE BUFFERED TISSUE MEDIA  
3.1 Introduction
Nitric oxide (NO) donors are used to study NO in cell signaling pathways using in
vitro models. As such, there is a real need to develop new analytical methods capable of 
analyzing NO release from NO donors in cell and tissue media. Current measurement 
methods used to monitor NO in vitro focus on measuring the byproducts of NO and are 
not typically performed in real time. To measure NO accurately under in vitro conditions, 
a measurement method is needed that is capable of analyzing NO generated from NO 
donors in buffered tissue media. As described in Chapter 2, 
Methylaminehexylmethylamine diazeniumdiolate (MAHMA/NO) was used to develop a 
NO release measurements method that yield total NO recovery and accurate half-lives for 
lower NO donor concentrations at pH 7.40 and 37 C in phosphate buffered saline (PBS). 
In this chapter, MAHMA/NO will be used again to develop a measurement method that 
allows for complete NO recovery and accurate MAHMA/NO half-lives in buffered tissue 
media at pH 7.40 and 37 C. To ensure the pH is indeed stable the method incorporates a 
real-time pH measurement probe.  Finally, to further demonstrate that this methodology 
is capable of measure NO release from NO donors under in vitro conditions, a 1.5 h NO 
release profile was collected for diethylenetriamine diazeniumdiolate (DETA/NO) 




Neurobasal tissue media (Invitrogen, phenol red & L-glutamine free), D-(+)-
glucose (Sigma Aldrich, 99.5%), 200 mM L-glutamine (Millipore), and L-glutamic acid 
(Fisher Scientific, 99.0-100.5%) were purchased comercially. Diethylenetriamine 
(DETA, Alfa Area, 99%) was purchased for NO donor synthesis, DETA/NO. DETA/NO 
was synthesized and purified in house following a detailed description described in 
section 3.3.1. For tissue media incubation experiments, a custom 5% carbon dioxide 
balanced with 95% nitrogen was purchased from Air Gas. Three pH calibration standards 
4.00, 7.00 and 10.00 were purchased from VWR. 
3.3 Methods 
3.3.1 Nitric Oxide Donor Synthesis 
DETA/NO was prepared according to a previously published report and is 
described in Section 2.3.1.5 The diazeniumdiolate was spectroscopically characterized for 
purity by UV spectroscopy at 252 nm. 
3.3.2 Real-time pH measurements  
All real-time pH analysis were measured using the Accumet Excel XL50 Dual 
Channel pH/Ion/Conductivity meter, which allowed for 1000 data point storage at a time 
interval as fast as 3 s. The pH probes that were used when performing the real-time pH 
analysis were Mettler Toledo In Lab Micro Pro (Ag/AgCl, 3M KCl). 
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Real-time pH Measurements Experimental Set-up 
A custom 3-port NOA sample cell was designed to incorporate a pH probe as shown in 
















The pH probe was oriented vertically within the custom 3-port reaction cell. Prior to 
insertion, the pH probe was fitted with an o-ring (105, ID 5/32” and OD 11/32”), and a 
septa vial cap. The pH probe head was submerged in at least by 0.5 cm of the sample 
solution. All real-time pH data was converted from an .html file to an Excel file and all 
measurements were processed using Excel. 
Figure 3.1: A diagram of the NO release measurement set-up with the 3-port custom 
NOA sample cell with the bubble and flow gas entrances (gas regulation), the 




 Evaluation of Custom 3-port Sample Cell and Real-Time pH Measurements by an Acid-
Base Titration 
The NOA instrument was turned on and 2 mL PBS buffer (pH 7.40) was added to 
the 3-port custom sample cell. The Mettler Toledo In Lab pH probe was attached to the 
Accumet Excel XL50 Dual Channel pH meter and calibrated. The pH probe was inserted 
into the 3-port sample cell as described previously. Real-time pH measurements were 
setup with a sampling interval of 5 s. Before any acid or base was titrated into the 3-port 
sample cell, a 24 points (~2 min) baseline was recorded. An aliquot of 50 l of 0.1 M 
HCl was injected into the sample inlet and the pH was recorded for 60 points (5 min). A 
total of nine injections shown in Table 3.1 were made to evaluate pH response of the pH 
probe under NO release measurement conditions.  












Injection Volume ( l) Acid/Base Injection Time Point
60 
 
3.3.3 Tissue Media Preparation
Fresh tissue media was prepared prior to each experiment to ensure freshness and 
proper buffering of the media. A 2.5 mM L-glutamic acid solution and a 45% glucose 
solution were prepared in 10 mL of Millipore treated water. Both solutions were stored in 
for 1 month at 4 °C.  In order to make a 100 mL tissue media, the following reagents 
were mixed together 97.63 mL Neurobasal media, 1 mL 2.5 mM L-glutamic acid, 1.1 mL 
45% glucose, and 248 l 200 mM glutamine. 
3.3.4 Nitric Oxide Release Measurements 
Nitric oxide release measurements were performed as described in section 2.3.2. 
3-port sample cell NO release experiment 
Nitric oxide release experiments were performed using the 3-port sample cell at 
the 8 mL buffer volume. These NO release experiments were performed as previously 
described in section 2.3.2 with a 11.8 mM MAHMA/NO stock.  
NO release experiments from 10-4 M MAHMA/NO decomposition in buffered tissue 
media 
Nitric oxide release experiments were performed as described previously in 
section 2.3.2, in 2 mL tissue media using the 3-port sample cell and with other minor 
modifications details below. The tissue media was buffered to pH ~7.40 with 5% CO2 gas 
at a bubbler gas rate of 20 mL/min rate and a flow gas rate of 178.4 mL/min. Real-time 
pH measurement were setup as described in section 3.3.2 at a sampling interval of 10 s. 
The data collection for pH and NO release began as soon as 5% CO2 encounters the 
tissue media and then, was continued for 1.5 h to ensure that the pH of the tissue media 
was buffered to pH ~7.40. Once the pH stabilized, a 20 l from either a 10.5 mM or a 
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13.9 mM MAHMA/NO solution prepared in 0.01 M NaOH was injected into the sample 
cell.  The NO release and real-time pH data were processed using Excel as described in 
section 2.3.2 and 3.2.2, respectively. 
NO release experiments from DETA/NO decomposition in buffered tissue media 
Nitric oxide release experiments were performed in 2 mL tissue media just like 
the previous 10-4 M MAHMA/NO experiment. After the tissue media was buffered to pH 
7.40 using 5% CO2 at a bubbler gas rate of 20 mL/min for approximately ~ 1 h, a 20 l 
aliquot of a 60 mM DETA/NO in 0.01 M NaOH stock was injected into the 3-port 
sample cell and NO release was measured for 1.5 h. The NO release and real-time pH 
data were processed using Excel as described in section 2.3.2 and 3.2.2, respectively. 
3.4 Results 
3.4.1 Method optimization to enable NO release measurement from MAHMA/NO 
decomposition in buffered tissue media 
The aim is to development a measurement method that can monitor NO release 
from NO donors in buffered tissue media at 37 C and pH 7.40. This is, in contrast to the 
PBS buffer experiments where the buffer range and capacity did not require an additional 
reagent to maintain pH 7.40. However, in the tissue media experiments 5% CO2 is used 
to buffer the tissue media by employing carbonic acid and bicarbonate buffering system. 
As in the previous chapter, MAHMA/NO NO recovery and MAHMA/NO half-lives will 
be used as a criteria to develop a NO release measurement system in tissue media 
buffered by CO2 at 37 C. 
This methodology is similar to the PBS experiments presented in Chapter 2, 
however, there are three major modifications that are needed to measure NO release from 
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MAHMA/NO in tissue media, pH 7.4. These modifications include: a) the incorporation 
of a pH probe for real-time pH measurements, b) the use of tissue media and c) the use of 
5% CO2 to buffer the pH of the media. Care was taken to avoid potential issues that could 
influence the NO recovery or the experimentally derived MAHMA/NO half-lives. These 
potential problems include: donor interaction with compounds in tissue media, ability to 
achieve, maintain and monitor stable pH through addition of CO2 and scavenging of NO 
by components within the tissue media. The biggest challenge was maintaining a constant 
pH of the tissue media. As discussed in Chapter 2, three factors will be used to certify the 
performance of this measurement method in buffered tissue media. These three factors 
are obtaining accurate MAHMA/NO half-lives, theoretical NO recovery and maintenance 
standardized experimental conditions (pH 7.40, 37 C). 
The incorporation of a micro pH probe into the experimental set-up as depicted in 
Figure 3.1 was designed to measure real-time pH measurements within the 3-port sample 
cell as the NO release measurements were collected. Further the pH probe was used to 
help determine the proper flow rate for 5% CO2 to adequately buffer the tissue media to 
pH 7.4 0.1. This created a dual system that could monitor both the NO release from  
MAHMA/NO decomposition and also, ensure that pH 7.4 was maintained.  The addition 
of a pH probe required a new 3-port custom sample cell be designed. Each port was 
designed to have a specific function to ensure that the measurements recorded within the 
sample cell are accurate and reproducible. The aim of the design was to 1) facilitate the 
incorporation of a pH probe into the cell, 2) not interfere with the amount of volume of 
buffer in the cell and 3) to create a sample cell that functions exactly the same as the 2-
port reaction cell used previously to collect NO release measurements. Finally, two 
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custom cells were designed to enable real-time pH measurement and NO release in two 
buffer volume ranges, small (2,4,6) and larger (8, 10) (Figure 3.2B,C).  
 
To ensure that the change from the 2-port to the 3-port sample cell did not influence the 
half-lives of MAHMA/NO decomposition, a control experiment was designed. A 
comparison of MAHMA/NO half-lives calculated from NO release data derived from 8 
mL PBS in the 3-port sample cells with the MAHMA/NO decomposition kinetics 
obtained in the 2 mL 2-port sample cell was performed. Previously in section 2.4.2, this 2 
mL experiment proved to be statistically similar at the 95% confidence interval with the 
60 s reported value for MAHMA/NO.  The 3-port 8 mL experiments were preformed 
exactly as the 2-port experiment discussed in section 2.3.2. Table 3.2 show a comparison 
of the experimental data produced using the 2mL 2-port and the 8 mL 3-port sample 
cells. Using the 3-port sample cell, MAHMA/NO half-lives of 68±2 were calculated and 
compared to the MAHMA/NO half-lives 63±4 from 10-4 M MAHMA/NO experiment in 
the 2-port sample cell. This comparison indicated that the addition of the third port into 
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the sample cell did not influence the MAHMA/NO kinetics. At the 99% confidence 
interval, these MAHMA/NO half-lives were determined to be statistically similar to each 
other and to the report literature value for MAHMA/NO.  
Table 3.2: Evaluating the Function of 3-port Sample Cell to the 2-port Sample Cell by 





Another important design consideration when designing for the sample cell for 
the integration of a pH probe was that the pH probe needed to be oriented vertically to 
produce the most accurate readings. Real-time pH measurements are extremely important 
to this measurement method because NO is derived from diazeniumdiolates and their 
decomposition is highly dependent on pH.6 To evaluate the responds time of the pH 
probe, a qualitative experiment was performed by titrating multiple injection volumes of 












As shown in Figure 3.3, the real-time pH response of the pH probe integrated into the 
NOA cell was rapid after multiple injection of either 0.1 M HCl (red) or 0.1 M NaOH 
(blue). This confirmed the pH probe’s ability to function while integrated into the NOA 
cell and to be used to monitor the real-time pH in the tissue media experiments.  
3.4.2 NO release measurements from 10-4 M MAHMA/NO in buffered tissue media 
Many in vitro studies using cell and tissue models are used to understand NO role 
in cellular behaviors, but no detection method exists for monitoring NO release in 
buffered tissue media. Three major modifications will be needed to transition from a PBS 
system to a buffered tissue media system at pH 7.40 and 37 C. The first is to transition 
the system from PBS buffer to Neurobasal tissue media. One challenge, in particular with 
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Neurobasal tissue media is that there is a large increase in the number and variety of 
species that could react or interfere with accurately measuring NO. The second major 
difference in the experimental protocol was the use of 5% CO2 in 95% nitrogen instead of 
100% nitrogen as the bubble and flow gas used in all previous NO release experiments. 
The third was real-time pH achieved through the incorporating a pH probe into the 
custom 3-port sample cell. These three changes will enable this measurement method to 
record real-time NO release measurement from NO donors in a CO2 buffered tissue 
media environment.  
In order to incorporate the needed amount of 5% CO2 to maintain the tissue media 
at pH 7.40, a pH probe was used to determine the appropriate flow rate of 5% CO2 by 
recording real-time pH measurements. A bubbler gas rate of 5% CO2 was needed to be 
experimentally determined and maintain the pH 7.4 ± 0.1 of the tissue media prior to the 
injection of NO donor.  The bubbler gas rate was determined to be 20 mL/min (178 
mL/min) to buffer 2 mL of tissue media at pH ~7.40. Figure 3.4 shows the pH response 
once 20 mL/min of 5% CO2 was added to 2 mL tissue media. There is an immediate pH 
response to the 5% CO2 and the pH stabilizes at approximately pH ~7.40 after 30 min. 
The pH response was monitored for 1.5 h prior to injecting 20 l of MAHMA/NO 
solution into the buffered tissue media to collect NO release from MAHMA/NO 
decomposition to ensure that the pH was indeed stable. The NO release data was 





Table 3.3 shows a summary of results from 10-4 M MAHMA/NO experiments in both 
PBS and Tissue Media at 2 mL volume.  
Table 3.3: Evaluating the Difference in Aqueous Environments on MAHMA/NO Half-
Lives and NO Recovery at pH 7.40, 37 °C 
 
By comparing the MAHMA/NO decomposition half-lives in tissue media to PBS 
(pH 7.4), the experimentally derived MAHMA/NO half-lives in tissue media and PBS 
buffer are very similar to each other. In tissue media, MAHMA/NO half-lives were found 
to be 68±5 with 99±8 percent NO recovery. When statistical analysis was performed 
between the experimentally derived MAHMA/NO half-lives in 2 mL PBS and 2 mL 
buffered tissue media, the half-lives were determined to be statistically similar at the 95% 
confidence interval. Since the MAHMA/NO half-lives were not change significantly, it 
can be concluded that the tissue media is not influencing MAHMA/NO decomposition.  
These experiments also shows that all of the theoretical NO released from MAHMA/NO 
was detected based on the spectroscopic concentration of MAHMA/NO. The NO 
recovery for these experiments was 99±8 percent. The complete NO recovery indicates 
that NO is not interacting with the species in the tissue media as there was no loss in total 





2 mL Tissue Media
















Figure 3.4: This figure shows the average pH response for addition of 5% carbon dioxide at 20 mL/min to the tissue 
media. After 1.6 h, 20 l of 11 mM MAHMA/NO solution was injected and NO release is observed from 
MAHMA/NO decomposition. 
NO Release from 10-4 M MAHMA/NO in Buffered Tissue Media 
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This is in contrast to an electrochemical detection method reported by Garthwaite et al. where 
total NO recovery was not demonstrated in tissue media.7 In the Garthwiate study, they observed 
a loss in NO recovery, which was attributed to consumption of NO through the formation of 
superoxide that converts NO in to peroxynitrite (ONOO-) in the Nuerobasal tissue media. I 
hypothesize that since the sample cell was deoxygenated in order to use chemiluminescence 
detection prior to MAHMA/NO injection. The removal of oxygen in the sample cell, allows this 
measurement method to detect the theoretical amount of NO in buffered tissue media. The 
removal of oxygen is a likely reason for differences in total NO recovery in these experiments 
and electrochemical studies where superoxide was proposed to be produced and scavenge NO in 
the Neurobasal tissue media. The superoxides was proposed to be produced by the interaction of 
oxygen with riboflavin or through the autooxidation of oxygen by a metal ion.7 Thus, the total 
NO recovery with the developed measurement method at 10-4 M provides an advantage over 
previously reported NO detection methods in tissue media.  
3.4.3 NO release Experiments with DETA/NO in Buffered Tissue Media 
 To demonstrate the versatility of this measurement method, another NO donor was used. 
DETA/NO has a half-life of 20 h, which is different than MAHMA/NO. This diazeniumdiolate 
decomposes by the same mechanism as MAHMA/NO, where 1 mol of DETA/NO yields 2 moles 





 Figure 3.5:  The decomposition reaction for DETA/NO in aqueous solution at pH 7.4, 37 C.  
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The longer half-life for DETA/NO allows us the ability to examine steady state NO release rates. 
DETA/NO’s release rate may be within the physiologically release range for NO in brain tissue, 
established to be 1800 to 0.38 nM.8  
 The experiment was performed by preparing fresh tissue media and adding 2 mL to the 3-
port custom sample cell. NO release measurements were measured at a 1 s data collection and 
pH response measurements were collected at 10 s interval. The tissue media was buffered to pH 
7.4 0.1 at a 20 mL/min rate of 5% CO2 and after 1 h, the pH stabilized to pH ~ 7.40 allowing 20 
l of a 60 mM DETA/NO stock to be injected into the buffered tissue media. The NO release 
profile for DETA/NO is shown in Figure 3.6, along with the pH response following the injection 
of DETA/NO in tissue media. After the injection of 20 l of a 60 mM DETA/NO solution, a 
steady-state release profile is observed over the 1.5 h. The pH response after injection stayed at 
pH ~7.4 for the entire 1.5 h timeframe. The total average NO release from DETA/NO in 1.5 h 
was 0.12 ±0.02 nmol. The NO release per s from DETA/NO averaged over the 1.5 h release was 
calculated to be 22 ±3 fmol/s. This NO release from DETA/NO decomposition may prove useful 
in probing the effect of lower concentrations of NO donor used in cell and tissue models. The 
NO release from DETA/NO decomposition showed that other NO donors can be analyzed using 
this measurement method and that longer experiments do not adversely influence the buffering 
pH of the tissue media.
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Figure 3.6: This figure shows the average pH response following a 20 l injection of 60 mM DETA/NO and the NO release 
profile from DETA/NO decomposition for 1.5 hr. 
0.25 0.5 0.75 1 1.25 1.5  0 
NO Release from DETA/NO in Buffered Tissue Media 
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3.5 Conclusions 
 In conclusion, I have demonstrated a complete measurement method that combines 
real-time pH and NO release measurement to measure NO from NO donor decomposition 
through NO release in buffered tissue media. This measurement method demonstrates the 
first analytical method to allow for NO release measurements in CO2 buffered tissue media 
(pH 7.40, 37 C) mimicking in vitro conditions. These measurements were enabled by the 
design of a custom 3-port sample cell to integrate a pH probe, which determine the proper 
bubbling rate of 5% CO2 to effectively buffer the Neurobasal tissue media at pH 7.40 0.1. 
This measurement method also, allowed accurate MAHMA/NO half-lives to be 
experimentally derived in 2 mL buffered tissue media finding that these experimentally 
derived half-lives were statistically similar at the 95% confidence interval to the 60 s 
literature reported value for MAHMA/NO.  Finally, this novel measurement method was 
shown to be effective in monitoring NO release from multiple NO donor, specifically, 
MAHMA/NO and DETA/NO, under simulated in vitro conditions. 
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4. FUTURE DIRECTION 
4.1 Future Directions 
The work presented in this thesis, focused on designing a measurement method that 
enabled measuring nitric oxide (NO) release from a wider range of NO donor concentrations, 
specifically measuring 10-4 M to 10-7 M MAHMA/NO donor concentrations. This 
measurement method may assist researchers in understanding NO’s role in physiology by 
offering greater insight to how NO concentration effect it’s biological activity. The second 
aim for developing this measurement method was to measure NO release from NO donor in 
carbon dioxide (CO2) buffered tissue media. However, developing better analytical methods 
does not end with these two measurement methods for measuring NO. I believe that there are 
many important questions that could still be addressed using this work is as a starting place. 
There are three important ideas that could be explored further to improve these NO 
measurement methods and to use these methods to better understand NO role in physiology.  
The first idea would be to further extend the concentration range for monitoring NO 
release from NO donor solution in the PBS system from 10-7 M to 10-9 M. An application of 
this measurement method is to achieve NO release from NO donors that matches specific 
concentration target for physiological levels of NO releases. These levels of NO release are 
typically achieved by using dilute NO donor concentrations. Thus, it is relevant to measure 
even more dilute NO donor concentrations. From the studies presented in Chapter 2, there 
were two modifications made to the chemiluminescence method to monitor NO release from 
a 4.4x10-7 M MAHMA/NO solution: adjusting the bubbler gas rate and increasing buffer 
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volume in the sample cell. Measuring NO release from 4.4x10-7 M MAHMA/NO in the 10 
mL buffer volume, a 59 mL/min bubbler flow rate was used. This bubbler gas rate almost 
exceeded the flow capacity for the size 1 flow meter. In order to increase the bubbler gas rate 
above 75.5 mL/min, a size 2 calibrated flow meter would be needed to modulate the bubbler 
flow gas for larger volumes of buffer. As the volume within the sample cell increases, 
additional circulation of the buffer within the sample cell may be needed through the addition 
of a stir bar or mechanical accessory. This will allow the measurement method to maintain 
accurate NO recovery, accurate MAHMA/NO half-lives and eliminate the effects of NO 
trapping, discussed in section 2.4.3. Provided that one can maintain accurate NO recovery 
and MAHMA/NO half-lives, this method has great potential for monitoring NO release from 
even lower concentrations of NO donors.  
 The second idea would be to monitor 10-7 M MAHMA/NO donor decomposition in 
CO2 buffered tissue media. As demonstrated in Chapter 3, MAHMA/NO and DETA/NO 
decomposition could be successfully monitored in 2 mL tissue media at 37 C and pH 7.40 
by measuring NO release. Quantification of the theoretical NO recovery and accurate 
MAHMA/NO half-lives were obtained in the 10-4 M MAHMA/NO experiments. Chapter 2, 
showed that NO release could be measured in 10 mL PBS from 10-7 M MAHMA/NO 
decomposition, while achieving accurate MAHMA/NO half-lives and complete NO 
recovery. To enable detection of NO release in buffered tissue media, the tissue media would 
need to be increased from 2 mL to 10 mL. Using the bubbler gas rate determined in chapter 2 
as a guide for determining the optimal bubbler rate conditions, the 10 mL tissue media 
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method would need to be optimized at the 10-4 M MAHMA/NO condition to maintain stable 
experimental conditions (pH 7.40, 37 C). This bubbler rate would need to be evaluated to 
maintain pH 7.4±0.1 and yield accurate MAHMA/NO half-lives. A major challenge arose in 
the preliminary work to optimize this measurement method to monitor NO release from 10-7 
M MAHMA/NO in buffered tissue media system and the challenge was that at 10-7 M 
MAHMA/NO, a significant drop in NO recovery was observed. A loss in NO recovery had 
not been observed in the 10-4 M MAHMA/NO studies. Figure 4.1 shows a comparison in the 
NO release from 10-7 M MAHMA/NO in the buffered tissue media (Figure 4.1A) and PBS 
(Figure 4.1 B). The NO release from 10-7 M MAHMA/NO in buffered tissue media (Figure 
4.1A) was an order of magnitude lower than the NO release observed in the 10-7 M 








The experimentally measured NO recovery for NO release from 10-7 M MAHMA/NO in 
buffered tissue media was found to be 8 2. This NO recovery is significantly less than the 
99 8 found in buffered tissue media at 10-4 M MAHMA/NO in section 3.4.2. This is also 
Figure 4.1: A direct comparison of the NO release profile in terms of mol NO for the 
10-7 M MAHMA/NO in buffered tissue (A) and 10-7 M MAHMA/NO in PBS (B).  
 77
significantly different at the 95% confidence interval, than the NO recovery of 117 2 
observed in the 10-7 M MAHMA/NO PBS studies. As discussed briefly in Chapter 3, there is 
a literature precedent by Garthwaite and colleagues for NO consumption in tissue media, 
specifically implicating Neurobasal tissue media.1 Neurobasal tissue media is the media used 
in all of the tissue media experiments presented in this work. In the electrochemical detection 
method for NO in Neurobasal tissue media, Garthwaite et al. reports a loss in NO recovery 
that was due to scavenging of NO by components within the tissue media. Specifically, they 
attribute the loss of NO recovery to NO conversion to peroxynitrite (ONOO-) by superoxide 
formed from oxygen (O2).1 In the 10-4 M MAHMA/NO studies in buffered tissue media, 
accurate NO recovery was observed and I attributed the complete NO recovery to the 
deoxygenation of the sample cell prior to donor injection. The deoxygenation of the cell 
would limit the formation of superoxide by preventing NO conversion to ONOO-. However, 
when the concentration of MAHMA/NO decreased significantly from 10-4 M to 10-7 M in 
preliminary studies, a significant loss of NO recovery was observed indicating that 
deoxygenation of the sample cell may not be enough when analyzing more dilute 
concentrations of NO donor, like 10-7 M. I hypothesize the loss of NO recovery was due to 
there being ample O2 within the 100 l injection volume, this resulted in a significant 
decrease in the total mol of NO detected. A possible way to increase the amount of NO 
measured in the 10-7 M MAHMA/NO studies in buffered tissue media is to deoxygenate the 
MAHMA/NO solution prior to NO donor injection into the sample cell.  This will removal 
excess oxygen and be a good control to see if accurate NO recovery could be restored. Prior 
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to increasing the concentration range of NO donor measured with this method, total NO 
recovery must be achieved in order to monitor dilute NO donor concentration in CO2 
buffered tissue media. 
 The establishment of NO release measurements from NO donor decomposition in 
tissue media allows this measurement method to be used to study the effect of NO on cellular 
migration in brain tissue by using NO release profiles from the NO donor. MAHMA/NO and 
DETA/NO established that NO release profiles for the NO donor decomposition could be 
obtained in buffered tissue media. However, ideally it be interesting to produce a wide range 
of NO release profile with different relative concentration rates for NO release. These 
different concentrations of NO from different NO donors could be used to screen in vitro cell 
and tissue models for the effect of NO. These experiments could reveal more about NO’s 
physiological effects. Using this measurement method, NO release profiles could be 
measured over a 1.5 h to customize NO donor concentrations, that would demonstrate NO 
release that is within the general physiological concentration of NO previously established to 
range from 1 M to 100 pM.2 The measurement method described in this thesis has been 
developed as a straight forward, bench-top real-time NO release measurement method 
capable of measuring NO release from NO donors in buffered tissue media. To measure NO 
release from NO donor in buffered tissue media, it is important to accurately buffer the tissue 
media with CO2 to pH 7.40 0.1.  
A potential application for this methodology is to look at developing NO release 
profiles from NO donors that are specifically within the physiological range in the brain from 
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1800 nM to 0.38 nM.2 Then use these NO release profiles to better understand the role NO 
plays in cellular migration with respect to NO concentration. The determination of NO 
release over a required 1.5 h was successful for DETA/NO, yielding a total NO delivery of 
0.6 ±0.1 nM in 1.5 h. The total NO recovery for DETA/NO over 1.5 h was within the 
targeted physiological range previously reported in the literature for in vivo NO release in 
brain tissue.1 The NO release rates from DETA/NO decomposition (average mol NO per s) 
over a 1.5 h release was calculated to be 11±15 pM/s. In order to quantifying larger NO 
recovery and to investigate the necessary amount of NO needed to stimulate cellular 
migration within brain slices, different NO donors could be explored that have half-life’s that 
fall between DETA/NO’s 20 h and MAHMA/NO 60 s. A half-life in between DETA/NO and 
MAHMA/NO would allow more NO to be released within the 1.5 h used in the cellular 
migration studies. Larger NO concentration would be used to explore the influence of the 
concentration of NO on cellular migration. There are two possible diazeniumdiolates with 
shorter half-life than DETA/NO, but longer half-life than MAHMA/NO. The first is a carbon 
based diazeniumdiolate, p-Bisdiazeniumdiolate benzene, with a half-life of 3.6 hours.3 The 
other is 1-[N-(3Aminopropyl)-N-(3-aminopropyl)]diazen-1-ium-1,2-diolate (DPTA/NO) 
with a reported half-life of 3 hours.4  These diazeniumdiolate NO donors have a shorter half-
life than DETA/NO, which will allow more NO to be released in the 1.5 h. The hope is that 
these NO release profiles obtained with these NO donor could be used to achieve a wider 
range of NO concentrations that are within the NO release range proposed for brain tissue to 
provide additional insight to the influence of NO on cellular migration in the brain. 
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 These were the questions that I was most drawn to when thinking about the next steps 
in advancing this measurement method that I have developed. I hope that this system is 
utilized to answer many questions that are not understood presently and provide useful NO 
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